Last update 01 Nov 2024
Gemigliptin/Dapagliflozin
Last update 01 Nov 2024
Overview
Basic Info
Drug Type Small molecule drug |
Synonyms gemigliptin/Dapagliflozin, Zemidapa |
Target |
Mechanism DPP-4 inhibitors(Dipeptidyl peptidase IV inhibitors), SGLT2 inhibitors(Sodium/glucose cotransporter 2 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhaseApproved |
First Approval Date KR (21 Jun 2022), |
Regulation- |
Login to view timeline
Structure
Molecular FormulaC21H25ClO6 |
InChIKeyJVHXJTBJCFBINQ-ADAARDCZSA-N |
CAS Registry461432-26-8 |
View All Structures (2)
Related
1
Clinical Trials associated with Gemigliptin/DapagliflozinClinical Trial to Compare the Pharmacokinetics, Safety and Tolerability of the FDC of Gemigliptin/Dapagliflozin 50/10 mg to Each Component of Gemigliptin 50 mg and Dapagliflozin 10 mg
100 Clinical Results associated with Gemigliptin/Dapagliflozin
Login to view more data
100 Translational Medicine associated with Gemigliptin/Dapagliflozin
Login to view more data
100 Patents (Medical) associated with Gemigliptin/Dapagliflozin
Login to view more data
100 Deals associated with Gemigliptin/Dapagliflozin
Login to view more data
R&D Status
Approved
10 top approved records. to view more data
Login
| Indication | Country/Location | Organization | Date |
|---|---|---|---|
| Diabetes Mellitus, Type 2 | KR | 21 Jun 2022 |
Developing
10 top R&D records. to view more data
Login
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Diabetes Mellitus, Type 2 | Phase 2 | - | 01 Oct 2020 |
Login to view more data
Clinical Result
Clinical Result
Indication
Phase
Evaluation
View All Results
Login to view more data
Translational Medicine
Boost your research with our translational medicine data.
login
or
Deal
Boost your decision using our deal data.
login
or
Core Patent
Boost your research with our Core Patent data.
login
or
Clinical Trial
Identify the latest clinical trials across global registries.
login
or
Approval
Accelerate your research with the latest regulatory approval information.
login
or
Regulation
Understand key drug designations in just a few clicks with Synapse.
login
or
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free